These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15339745)

  • 1. Mechanism, temporal patterns, and magnitudes of the metabolic responses to the KATP channel agonist diazoxide.
    Raju B; Cryer PE
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E80-5. PubMed ID: 15339745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia.
    Ramanathan RP; Arbeláez AM; Cryer PE
    Diabetes; 2011 Apr; 60(4):1324-8. PubMed ID: 21378174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
    Staten MA; Matthews DE; Cryer PE; Bier DM
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal insulin, glucagon, and growth hormone replacement.
    Breckenridge SM; Raju B; Arbelaez AM; Patterson BW; Cooperberg BA; Cryer PE
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1303-10. PubMed ID: 17711984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations.
    Lucidi P; Murdolo G; Di Loreto C; Parlanti N; De Cicco A; Fatone C; Taglioni C; Fanelli C; Broglio F; Ghigo E; Bolli GB; Santeusanio F; De Feo P
    Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):410-7. PubMed ID: 16314227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction.
    Christensen NJ; Videbaek J
    J Clin Invest; 1974 Aug; 54(2):278-86. PubMed ID: 4847245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postexercise dose-response relationship between plasma glucose and insulin secretion.
    Mikines KJ; Farrell PA; Sonne B; Tronier B; Galbo H
    J Appl Physiol (1985); 1988 Mar; 64(3):988-99. PubMed ID: 3284873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antagonistic action of intestinal hormones and diazoxide on insulin secretion in humans].
    Raptis S; Schröder KE; Faulhaber JD; Pfeiffer EF
    Horm Metab Res; 1969 May; 1(3):116-21. PubMed ID: 4946718
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
    Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
    J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans.
    Raju B; Cryer PE
    Diabetes; 2005 Mar; 54(3):757-64. PubMed ID: 15734853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of insulin secretion following long-term manipulation of ATP-sensitive potassium channels by diazoxide and nateglinide.
    Ball AJ; Flatt PR; McClenaghan NH
    Biochem Pharmacol; 2005 Jan; 69(1):59-63. PubMed ID: 15588714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of KATP channel modulators on counterregulatory responses and cognitive function during acute controlled hypoglycaemia in healthy men: a pilot study.
    Bingham E; Hopkins D; Pernet A; Reid H; Macdonald IA; Amiel SA
    Diabet Med; 2003 Mar; 20(3):231-7. PubMed ID: 12675669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence against important catecholamine compensation for absent glucagon counterregulation.
    De Feo P; Perriello G; Torlone E; Fanelli C; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E203-12. PubMed ID: 1996624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of prostaglandin E2 infusion in man: possible adrenergic mediation.
    Newman WP; Brodows RG
    J Clin Endocrinol Metab; 1982 Sep; 55(3):496-501. PubMed ID: 7047549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic actions of alanine and terbutaline in IDDM.
    Wiethop BV; Cryer PE
    Diabetes Care; 1993 Aug; 16(8):1124-30. PubMed ID: 8375242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in insulin secretion in diabetes after diazoxide.
    Greenwood RH; Mahler RF; Hales CN
    Lancet; 1976 Feb; 1(7957):444-7. PubMed ID: 55717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
    Berk MA; Clutter WE; Skor D; Shah SD; Gingerich RP; Parvin CA; Cryer PE
    J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting.
    Boyle PJ; Shah SD; Cryer PE
    Am J Physiol; 1989 May; 256(5 Pt 1):E651-61. PubMed ID: 2655471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminophylline stimulates insulin secretion in patients with type 2 diabetes mellitus.
    Arias AM; Bisschop PH; Ackermans MT; Nijpels G; Endert E; Romijn JA; Sauerwein HP
    Metabolism; 2001 Sep; 50(9):1030-5. PubMed ID: 11555834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.